ALLO-501,allo-501A
allogene therapeutics
['$allo']
clarification from $allo: 2/5 ongoing cr &gt;6mth are 501a (pt 4 = 501).
2/3 relapsers after short response are 501a.
2/4 pd patients are 501a. #asco23
Once had a blue tick. Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.